Cyclosporine modulates the response to hypoxia-reoxygenation in pulmonary artery endothelial cells

Annals of Thoracic Surgery

Volumn 79, Issue 3, 2005, Pages 1010-1016

  Farivar, Alexander S ^a   Mackinnon Patterson, Brendan C ^a   Barnes, Andrew D ^a   McCourtie, Anton S ^a   Mulligan, Michael S ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CREMAPHOR; CYCLOSPORIN A; CYTOKINE; DRUG VEHICLE; EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HYPOXIC CELL; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SECRETION; PULMONARY ARTERY; RAT; REOXYGENATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 14244261142     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.08.078     Document Type: Article

References (40)

1. M. de Perrot, M. Liu, T. Waddell, S. Keshavjee Ischemia-reperfusion- induced lung injury Am J Resp Crit Care Med 167 2003 490 511
2. S.M. Fiser, C.G. Tribble, S.M. Long Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome Ann Thorac Surg 73 2002 1041 1047
3. S.M. Fiser, C.G. Tribble, S.M. Long Pulmonary macrophages are involved in reperfusion injury after lung transplantation Ann Thorac Surg 71 2001 1134 1138
4. A.S. Farivar, S.M. Woolley, C.H. Fraga, K. Byrne, M.S. Mulligan Proinflammatory response of alveolar type II pneumocytes to in vitro hypoxia and reoxygenation Am J Transplant 4 2004 346-51
5. M.J. Eppinger, M.L. Jones, G.M. Deeb, S.F. Bolling, P.A. Ward Pattern of injury and the role of neutrophils in reperfusion injury of rat lung J Surg Res 58 1995 713 718
6. B.V. Naidu, S.M. Woolley, A.S. Farivar Early tumor necrosis factor-α release from the pulmonary macrophage in lung ischemia-reperfusion injury J Thorac Cardiovasc Surg 127 2004 1502 1508
7. T.S. Maxey, R.I. Enelow, B. Gaston Tumor necrosis factor-α from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury J Thorac Cardiovasc Surg 127 2004 541 547
8. B.V. Naidu, B. Krishnadasan, A.S. Farivar Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury J Thorac Cardiovasc Surg 126 2003 200 207
9. M. de Perrot, K. Young, Y. Imai Recipient T cells mediate reperfusion injury after lung transplantation in the rat J Immunol 171 2003 4995 5002
10. S.D. Ross, C.G. Tribble, J.R. Gaughen Jr Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation Ann Thorac Surg 67 1999 1428 1433
11. Y.H. Lien, L.W. Lai, A.L. Silva Pathogenesis of renal ischemia/reperfusion injury: lessons from knockout mice Life Sci 74 2003 543 552
12. E.M. Boyle Jr, T.G. Canty Jr, E.N. Morgan Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription Ann Thorac Surg 68 1999 1949 1953
13. E.M. Boyle Jr, T.H. Pohlman, C.J. Cornejo, E.D. Verrier Endothelial cell injury in cardiovascular surgery: ischemia-reperfusion Ann Thorac Surg 62 1996 1868 1875
14. M.B. Forman, D.W. Puett, R. Virmani Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications J Am Coll Cardiol 13 1989 450 459
15. A. Kumar, S. Lunu, R. Malya Mechanical stretch activates NFκB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma FASEB J 17 2003 1800 1811
16. J.V. Bonventre Molecular response to cytotoxic injury: role of inflammation, MAP kinases, and endoplasmic reticulum stress response Semin Nephrol 23 2003 439 448
17. B. Sun, H. Fan, T. Honda Activation of NFκB and expression of ICAM-1 in ischemic-reperfused canine myocardium J Mol Cell Cardiol 33 2001 109 119
18. J. Paik, J.Y. Lee, D. Hwang Signaling pathways for TNFa-induced COX-2 expression: mediation through MAP kinases and NFκB Adv Exp Med Biol 507 2002 503 508
19. W.Y. Ma, C. Huang, Z. Dong Inhibition of ultraviolet C irradiation-induced AP-1 activity by aspirin is through inhibition of JNKs but not Erk or P38 MAP kinase Int J Oncol 12 1998 565 568
20. S.M. Woolley, A.S. Farivar, B.V. Naidu Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion J Thorac Cardiovasc Surg 127 2004 376 384
21. B.V. Naidu, B. Krishnadasan, K. Byrne Regulation of chemokine expression by cyclosporine A in alveolar macrophages exposed to hypoxia and reoxygenation Ann Thorac Surg 74 2002 899 905
22. U. Ryan Isolation and culture of pulmonary endothelial cells Environ Health Perspect 56 1984 103 114
23. W.W. Carley, M.J. Niedbala, M.E. Gerritsen Isolation, cultivation, and partial characterization of microvascular endothelium derived from human lung Am J Respir Cell Mol Biol 7 1992 620 630
24. P. Collins, M. Wilkie, K. Razak, S. Abbot, S. Harley, C. Bax Cyclosporine and cremaphor modulate von Willebrand factor release from cultured human endothelial cells Transplantation 56 1993 1218 1223
25. F.E. Mackie, D. Umetsu, O. Salvatierra, M.M. Sarwal Pulmonary capillary leak syndrome with intravenous cyclosporin A in pediatric renal transplantation Pediatr Transplant 4 2000 35 38
26. E.N. Morgan, E.M. Boyle Jr, W. Yun An essential role for NF-κB in the cardioadaptive response to ischemia Ann Thorac Surg 68 1999 377 382
27. B.V. Naidu, A.S. Farivar, S.M. Woolley, K. Byrne, M.S. Mulligan Chemokine response of pulmonary artery endothelial cells to hypoxia and reoxygenation J Surg Res 114 2003 163 171
28. S.F. Yan, T. Fujita, J. Lu Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress Nat Med 6 2000 1355 1361
29. H. Schramek MAP kinases: from intracellular signals to physiology and disease News Physiol Sci 17 2002 62 67
30. H. Kan, M. Finkel Inflammatory mediators and reversible myocardial dysfunction J Cell Physiol 195 2003 1 11
31. A. Bowie, L.A. O'Neill Oxidative stress and nuclear factor-κB activation: a reassessment of the evidence in the light of recent discoveries Biochem Pharmacol 59 2000 13 23
32. P.J. Barnes, M. Karin Nuclear factor-κB--a pivotal transcription factor in inflammatory diseases N Engl J Med 366 1997 1066 1071
33. G.L. Semenza Oxygen-regulated transcription factors and their role in pulmonary disease Respir Res 1 2000 159 162
34. L. Shi, R. Kishore, M. McMullen, L. Nagy LPS stimulation of ERK 1/2 increases TNF-a production via EGR-1 Am J Cell Physiol 282 2002 1205 1211
35. J.C. Hong, B.D. Kahan Immunosuppressive agents in organ transplantation: past, present, and future Semin Nephrol 20 2000 108 125 Review
36. J.W. Phillis, F.G. Diaz, M.H. O'Regan, J.G. Pilitsis Effects of immunosuppressants, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex Brain Res 957 2002 12 24
37. P.C. Waldmeier, K. Zimmermann, T. Qian, M. Tintelnot-Blomley, J.J. Lemasters Cyclophilin D as a drug target Curr Med Chem 10 2003 1485 1506
38. M. Ennis, W. Lorenz, B. Kapp, L. Luben, A. Schmal Comparison of the histamine releasing activity of cremaphor EL and some of its derivatives in two experimental models Agents Actions 16 1985 265
39. C. Zoja, L. Furci, F. Ghilardi Cyclosporin induced endothelial cell injury Lab Invest 55 1986 455 462
40. W.J. Sandborn, R.M. Strong, S.C. Forland, R.E. Chase, R.E. Cutler The pharmacokinetics of cyclosporine after IV, oral, and enema administration J Clin Pharmacol 31 1991 76 84